Playback speed×Share postShare post at current timeShare from 0:000:00/Paid episodeThe full episode is only available to paid subscribers of JNap’s Biotech ThoughtsSubscribe to watchPreviewing Larimar's June UpdateJNapMay 14, 2026∙ Paid4ShareHello Subs!This video walks you through what I’m hoping to see when LRMR presents the updated open-label data (likely in June 2026).I also walk you through my financial/valuation model.Cheers,JNapSubscribeContinue reading this post for free, courtesy of JNap.Claim my free postOr purchase a paid subscription.JNap PodcastSubstack for Remsen Investors LP, Bio5C, and anyone else interested in biopharma investing!Substack for Remsen Investors LP, Bio5C, and anyone else interested in biopharma investing!SubscribeListen onSubstack AppApple PodcastsSpotifyRSS FeedAppears in episodeJNapRecent EpisodesFull Top Ideas ReviewMay 21 • JNapPharvaris (PHVS) - Two Blockbuster HAE AssetsMay 13 • JNapA Lotto Idea In IPF?May 4 • JNapWhy I like PHVS, PTGX, & RVMD.Apr 29 • JNapUpdates - April 22, 2026Apr 22 • JNapCYTK Options Trade - ExplainedApr 17 • JNapWent Long This Potential 5X'erApr 15 • JNap